Hisamitsu Pharmaceutical Co Inc
TSE:4530
Hisamitsu Pharmaceutical Co Inc
TSE:4530
Price:
3 750 JPY
-1.55%
Updated:
May 21, 2024
Balance Sheet
Balance Sheet Decomposition
Hisamitsu Pharmaceutical Co Inc
Hisamitsu Pharmaceutical Co Inc
| Current Assets | 194B |
| Cash & Short-Term Investments | 125.3B |
| Receivables | 43B |
| Other Current Assets | 25.7B |
| Non-Current Assets | 134.8B |
| Long-Term Investments | 67.1B |
| PP&E | 49.5B |
| Intangibles | 6.8B |
| Other Non-Current Assets | 11.3B |
| Current Liabilities | 45.9B |
| Accounts Payable | 16.3B |
| Accrued Liabilities | 1.8B |
| Other Current Liabilities | 27.8B |
| Non-Current Liabilities | 18B |
| Long-Term Debt | 679m |
| Other Non-Current Liabilities | 17.3B |
Balance Sheet
Hisamitsu Pharmaceutical Co Inc
Hisamitsu Pharmaceutical Co Inc
Currency: JPY
| Feb-2015 | Feb-2016 | Feb-2017 | Feb-2018 | Feb-2019 | Feb-2020 | Feb-2021 | Feb-2022 | Feb-2023 | Feb-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
71 298
|
81 584
|
80 280
|
117 189
|
110 283
|
107 051
|
114 254
|
129 290
|
122 154
|
112 459
|
|
| Cash Equivalents |
71 298
|
81 584
|
80 280
|
117 189
|
110 283
|
107 051
|
114 254
|
129 290
|
122 154
|
112 459
|
|
| Short-Term Investments |
25 192
|
30 895
|
32 767
|
14 759
|
20 946
|
34 878
|
21 743
|
13 141
|
14 714
|
12 862
|
|
| Total Receivables |
46 252
|
37 355
|
35 772
|
34 946
|
39 662
|
48 907
|
39 203
|
38 112
|
39 753
|
42 983
|
|
| Accounts Receivables |
46 252
|
37 355
|
35 772
|
34 946
|
39 662
|
48 907
|
39 203
|
38 112
|
39 753
|
42 983
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
15 450
|
15 915
|
17 687
|
16 970
|
15 758
|
15 458
|
18 568
|
16 412
|
18 922
|
21 176
|
|
| Other Current Assets |
7 123
|
6 011
|
5 591
|
6 201
|
4 769
|
2 957
|
4 293
|
3 221
|
3 631
|
4 542
|
|
| Total Current Assets |
165 315
|
171 760
|
172 097
|
190 065
|
191 418
|
209 251
|
198 061
|
200 176
|
199 174
|
194 022
|
|
| PP&E Net |
45 003
|
43 851
|
43 031
|
40 064
|
39 556
|
38 596
|
37 354
|
39 069
|
43 209
|
49 462
|
|
| PP&E Gross |
45 003
|
43 851
|
43 031
|
40 064
|
39 556
|
38 596
|
37 354
|
39 069
|
43 209
|
49 462
|
|
| Accumulated Depreciation |
59 296
|
65 415
|
67 954
|
71 013
|
73 220
|
75 551
|
77 660
|
80 359
|
83 459
|
87 306
|
|
| Intangible Assets |
11 355
|
8 617
|
5 973
|
4 100
|
1 990
|
1 469
|
1 178
|
1 326
|
946
|
5 387
|
|
| Goodwill |
0
|
3 905
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1 444
|
|
| Long-Term Investments |
48 779
|
48 234
|
49 989
|
57 169
|
53 521
|
48 379
|
54 602
|
52 519
|
60 845
|
67 121
|
|
| Other Long-Term Assets |
10 040
|
8 587
|
7 730
|
8 515
|
9 301
|
9 706
|
8 666
|
9 768
|
9 743
|
11 343
|
|
| Other Assets |
0
|
3 905
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1 444
|
|
| Total Assets |
285 440
N/A
|
284 954
0%
|
278 820
-2%
|
299 913
+8%
|
295 786
-1%
|
307 401
+4%
|
299 861
-2%
|
302 858
+1%
|
313 917
+4%
|
328 779
+5%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
17 851
|
14 016
|
14 380
|
13 911
|
14 154
|
19 024
|
14 799
|
13 225
|
14 918
|
16 263
|
|
| Accrued Liabilities |
2 249
|
1 940
|
1 708
|
1 674
|
1 629
|
1 558
|
1 350
|
1 363
|
1 340
|
1 831
|
|
| Short-Term Debt |
1 560
|
1 605
|
1 490
|
1 390
|
1 290
|
1 140
|
1 040
|
1 000
|
1 000
|
0
|
|
| Current Portion of Long-Term Debt |
249
|
111
|
93
|
100
|
97
|
137
|
172
|
372
|
398
|
1 421
|
|
| Other Current Liabilities |
22 412
|
23 325
|
14 754
|
17 863
|
13 184
|
19 196
|
12 696
|
16 200
|
24 922
|
26 423
|
|
| Total Current Liabilities |
44 299
|
40 997
|
32 425
|
34 938
|
30 354
|
41 055
|
30 057
|
32 160
|
42 578
|
45 938
|
|
| Long-Term Debt |
788
|
689
|
608
|
568
|
503
|
498
|
390
|
1 088
|
897
|
679
|
|
| Deferred Income Tax |
3 775
|
5 730
|
5 525
|
7 823
|
5 222
|
2 978
|
5 125
|
4 170
|
1 813
|
4 518
|
|
| Minority Interest |
1 031
|
1 000
|
1 097
|
1 227
|
1 295
|
1 470
|
1 510
|
1 717
|
2 042
|
2 205
|
|
| Other Liabilities |
11 050
|
11 443
|
11 057
|
11 357
|
11 078
|
12 124
|
10 480
|
10 555
|
10 221
|
10 562
|
|
| Total Liabilities |
64 417
N/A
|
59 859
-7%
|
50 712
-15%
|
55 913
+10%
|
48 452
-13%
|
58 125
+20%
|
47 562
-18%
|
49 690
+4%
|
57 551
+16%
|
63 902
+11%
|
|
| Equity | |||||||||||
| Common Stock |
8 473
|
8 473
|
8 473
|
8 473
|
8 473
|
8 473
|
8 473
|
8 473
|
8 473
|
8 473
|
|
| Retained Earnings |
199 990
|
210 826
|
224 417
|
236 641
|
249 548
|
231 420
|
233 608
|
236 446
|
235 829
|
242 912
|
|
| Additional Paid In Capital |
8 396
|
8 396
|
5 914
|
5 914
|
5 914
|
2 272
|
2 352
|
2 356
|
2 361
|
2 361
|
|
| Unrealized Security Profit/Loss |
16 546
|
17 004
|
18 216
|
22 915
|
20 799
|
15 837
|
19 955
|
18 711
|
20 445
|
25 455
|
|
| Treasury Stock |
21 854
|
26 033
|
34 705
|
34 709
|
40 886
|
11 730
|
11 495
|
19 527
|
27 196
|
36 993
|
|
| Other Equity |
9 472
|
6 429
|
5 793
|
4 766
|
3 486
|
3 004
|
594
|
6 709
|
16 454
|
22 669
|
|
| Total Equity |
221 023
N/A
|
225 095
+2%
|
228 108
+1%
|
244 000
+7%
|
247 334
+1%
|
249 276
+1%
|
252 299
+1%
|
253 168
+0%
|
256 366
+1%
|
264 877
+3%
|
|
| Total Liabilities & Equity |
285 440
N/A
|
284 954
0%
|
278 820
-2%
|
299 913
+8%
|
295 786
-1%
|
307 401
+4%
|
299 861
-2%
|
302 858
+1%
|
313 917
+4%
|
328 779
+5%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
86
|
85
|
84
|
84
|
83
|
82
|
82
|
80
|
78
|
76
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
